Matches in Wikidata for { <http://www.wikidata.org/entity/Q94556362> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q94556362 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94556362 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94556362 description "scientific article published on 05 May 2020" @default.
- Q94556362 description "wetenschappelijk artikel" @default.
- Q94556362 description "наукова стаття, опублікована 5 травня 2020" @default.
- Q94556362 name "Design, antihuman immunodeficiency activity and molecular docking studies of synthesized 2-aryl and 2-pyrimidinyl pyrrolidines" @default.
- Q94556362 name "Design, antihuman immunodeficiency activity and molecular docking studies of synthesized 2-aryl and 2-pyrimidinyl pyrrolidines" @default.
- Q94556362 type Item @default.
- Q94556362 label "Design, antihuman immunodeficiency activity and molecular docking studies of synthesized 2-aryl and 2-pyrimidinyl pyrrolidines" @default.
- Q94556362 label "Design, antihuman immunodeficiency activity and molecular docking studies of synthesized 2-aryl and 2-pyrimidinyl pyrrolidines" @default.
- Q94556362 prefLabel "Design, antihuman immunodeficiency activity and molecular docking studies of synthesized 2-aryl and 2-pyrimidinyl pyrrolidines" @default.
- Q94556362 prefLabel "Design, antihuman immunodeficiency activity and molecular docking studies of synthesized 2-aryl and 2-pyrimidinyl pyrrolidines" @default.
- Q94556362 P1433 Q94556362-3FB96803-C88A-4B1C-A0E6-FD6E5F5844ED @default.
- Q94556362 P1476 Q94556362-8B4D7B3F-1CB3-4FB8-905F-10BA10FE1625 @default.
- Q94556362 P2093 Q94556362-26AB58D5-5694-4FFC-98EE-693FA912CA8D @default.
- Q94556362 P2093 Q94556362-29F3D4A0-2303-4E04-AD29-B15DE6E51C62 @default.
- Q94556362 P2093 Q94556362-5211447E-EE26-45F3-A31C-06DC96A34940 @default.
- Q94556362 P2093 Q94556362-5550BF88-00CE-4987-826D-82D05BAD366D @default.
- Q94556362 P2093 Q94556362-7C8DE74C-2EB0-4332-B221-A05B7D34563D @default.
- Q94556362 P2093 Q94556362-DBC53B76-FEA0-42DB-ACC9-6900155508AE @default.
- Q94556362 P2860 Q94556362-0B4AA92A-907B-4703-A7DE-36A1295DD57C @default.
- Q94556362 P31 Q94556362-76E301FD-DA82-4449-A07A-5319DB18569A @default.
- Q94556362 P356 Q94556362-1C1E9916-625E-4FC8-B123-7021CB6DFAD6 @default.
- Q94556362 P50 Q94556362-9E971EC1-7308-43C4-8C64-47A307F1E18F @default.
- Q94556362 P577 Q94556362-678CFE88-B8E3-47BD-A035-8A05638A710B @default.
- Q94556362 P698 Q94556362-E390AC5D-0BDB-415B-ACB2-41AF594B0503 @default.
- Q94556362 P356 S11030-020-10095-1 @default.
- Q94556362 P698 32372249 @default.
- Q94556362 P1433 Q3319469 @default.
- Q94556362 P1476 "Design, antihuman immunodeficiency activity and molecular docking studies of synthesized 2-aryl and 2-pyrimidinyl pyrrolidines" @default.
- Q94556362 P2093 "Ashot H Martirosyan" @default.
- Q94556362 P2093 "Garri V Chilingaryan" @default.
- Q94556362 P2093 "Gohar K Harutyunyan" @default.
- Q94556362 P2093 "Marina V Alexanyan" @default.
- Q94556362 P2093 "Raymond F Schinazi" @default.
- Q94556362 P2093 "Steve Coats" @default.
- Q94556362 P2860 Q21092922 @default.
- Q94556362 P31 Q13442814 @default.
- Q94556362 P356 "10.1007/S11030-020-10095-1" @default.
- Q94556362 P50 Q94556360 @default.
- Q94556362 P577 "2020-05-05T00:00:00Z" @default.
- Q94556362 P698 "32372249" @default.